论文部分内容阅读
目的:分析血必净联合乌司他丁在治疗重症脓毒症中的临床效果。方法:将我院收治的重症脓毒症患者作为本次实验的研究对象,利用随机数表法,划分为甲组研究组及乙组研究组。分别给予血必净以及血必净联合乌司他丁进行治疗,对临床治疗效果进行分析。结果:对甲组和乙组的临床指标进行比较和分析,乙组的机械通气时间和ICU住院时间明显少于甲组,P<0.05。结论:对重症脓毒症患者采用血必净联合乌司他丁进行治疗,能缓解临床不良反应,整体优势突出。
Objective: To analyze the clinical effect of Xuebijing combined with ulinastatin in the treatment of severe sepsis. Methods: The severe sepsis patients treated in our hospital as the object of this study, the use of random number table method, divided into Group A and Group B study group. Were given Xuebijing and Xuebijing combined with ulinastatin for treatment, the clinical treatment effect analysis. Results: The clinical indexes of Group A and Group B were compared and analyzed. The duration of mechanical ventilation and ICU stay in Group B was significantly less than that in Group A (P <0.05). Conclusion: The treatment of severe sepsis patients with Xuebijing combined with ulinastatin can relieve clinical adverse reactions, the overall advantages of outstanding.